Track the CONTROL BIONICS LIMITED share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are listed on the AU market, under the supervision of ASX. Market capitalisation: €27.6m. The latest transaction was disclosed on 12 August 2026 (Change in Substantial Holding). Among the most active insiders: Nightingale Partners Pty Ltd. The full history is openly available.
8
Insider Decl.
n/a
Thresholds
€206,251
6 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
Buys €206,251n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,083 of 28,857 companies
28.0
score / 100
Value
11
Quality
45
FCF yld-17%
Earn yld-18%
EV/EBITDA·
ROE-92%
Gross mgn72%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
400,000 shares@ A$0.075100.0% of flowShareASXISINISIN AU0000114183ASX:2924-03112768-2A1685272
8 of 8 declarations
About CONTROL BIONICS LIMITED
CONTROL BIONICS LIMITED is a company listed on the ASX, specializing in the development of assistive technologies for individuals with communication disorders. It focuses on innovation in communication and control devices to enhance the quality of life for users.